TickerFacts.

Idexx Laboratories Inc (IDXX): Net Income

Annual figures by period end, from SEC filings.

$1.06B
Year ended 2025-12-31
$1.14B
Trailing 12 months to 2026-06-30
+16.0%
3-year compound annual growth
+12.7%
5-year compound annual growth
+18.6%
10-year compound annual growth
2008-12-31: $116.17M2009-12-31: $122.22M2010-12-31: $141.28M2011-12-31: $161.79M2012-12-31: $178.27M2013-12-31: $187.80M2014-12-31: $181.91M2015-12-31: $192.08M2016-12-31: $222.04M2017-12-31: $263.14M2018-12-31: $377.03M2019-12-31: $427.72M2020-12-31: $581.78M2021-12-31: $744.85M2022-12-31: $679.09M2023-12-31: $845.04M2024-12-31: $887.87M2025-12-31: $1.06B$1.06B
2008-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$1.06B+19.3%2026-02-20, From 2025-01-01
2024-12-31$887.87M+5.1%2026-02-20, From 2024-01-01
2023-12-31$845.04M+24.4%2026-02-20, From 2023-01-01
2022-12-31$679.09M-8.8%2025-02-21, From 2022-01-01
2021-12-31$744.85M+28.0%2024-02-22, From 2021-01-01
2020-12-31$581.78M+36.0%2023-02-16, From 2020-01-01
2019-12-31$427.72M+13.4%2022-02-16, From 2019-01-01
2018-12-31$377.03M+43.3%2021-02-12, From 2018-01-01
2017-12-31$263.14M+18.5%2020-02-14, From 2017-01-01
2016-12-31$222.04M+15.6%2019-02-15, From 2016-01-01
2015-12-31$192.08M+5.6%2018-02-16, From 2015-01-01
2014-12-31$181.91M-3.1%2017-02-17, From 2014-01-01
2013-12-31$187.80M+5.3%2016-02-17, From 2013-01-01
2012-12-31$178.27M+10.2%2015-02-17, From 2012-01-01
2011-12-31$161.79M+14.5%2014-02-18, From 2011-01-01
2010-12-31$141.28M+15.6%2013-02-19, From 2010-01-01
2009-12-31$122.22M+5.2%2012-02-17, From 2009-01-01
2008-12-31$116.17Mn/a2011-02-22, From 2008-01-01

Net Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Idexx Laboratories Inc (IDXX)2025-12-31$1.06B+19.3%
QuidelOrtho Corp (QDEL)2025-12-28-$1.13Bn/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$233.56M-25.2%
Neogen Corp (NEOG)2026-05-31-$7.90Mn/m
Myriad Genetics Inc (MYGN)2025-12-31-$365.90Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$412.69Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$17.26Mn/m
Immucell Corp (ICCC)2025-12-31-$1.04Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$12.78Mn/m

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗